Article

Real-World Implementation of CYP2C19 Pharmacogenetic Testing in Clopidogrel-Treated Patients: Insights from French Clinical Data

2026-04-19

Abstract excerpt

<title>Abstract</title> <p>Clopidogrel is a highly prescribed antiplatelet prodrug that requires activation by CYP2C19. Loss-of-function variants, such as CYP2C19*2, may reduce its efficacy and increase the risk of cardiovascular events. This study aimed to evaluate the real-world implementation of CYP2C19 pharmacogenetic testing in patients treated with clopidogrel, using data from a French clinical data reposit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2150bc41-50f8-508e-b765-89fef85e9056
DOI: 10.21203/rs.3.rs-9314427/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Real-World Implementation of CYP2C19 Pharmacogenetic Testing in Clopidogrel-Treated Patients: Insights from French Clinical DataDOI 10.21203/rs.3.rs-9314427/v1Read

CYP2C19 Pharmacogenetics and Clopidogrel Prescription in a University Hospital: A Descriptive Study in a Clinical Data WarehouseSemantic proximity Read

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice.Semantic proximity Read

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).Semantic proximity Read

Implementation of clopidogrel pharmacogenetics: a Brazilian perspective.Semantic proximity Read

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.Semantic proximity Read

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.Semantic proximity Read

Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives.Semantic proximity Read

Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program.Semantic proximity Read

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative.Semantic proximity Read

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.Semantic proximity Read

CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls.Semantic proximity Read

Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.Semantic proximity Read